medecolМедицина и экологияMedicine and ecology2305-60452305-6053Карагандинский медицинский университетmedecol-387Research ArticleКЛИНИЧЕСКАЯ МЕДИЦИНАCLINICAL MEDICINEНовые подходы к диагностике хронической обструктивной болезни легкихNew approaches for diagnostic of chronic obstructive pulmonary diseaseЧескаА.CheşcăA.

Антонелла Ческа – руководитель лаборатории визуальных методов,  Факультет медицины

Брашов

Antonella Cheşcă – Head of Imagistics Lab. at Lung  Phthysiology Hospital

Braşov

anto.chesca@gmail.comЧескаС. А.CheşcăS. A.

Брашов

СэндлТ.SandleT.Больница фтизиатрии легких; университет ТрансильванииРумынияTransilvania University of BraşovRomaniaГоспиталь психиатрии и неврологииРумынияPsychiatry and Neurology Hospital BraşovRomaniaУниверситет МанчестераВеликобританияUniversity of ManchesterUnited Kingdom202104062023042630Copyright © Ческа А., Ческа С.А., Сэндл Т., 20232023Ческа А., Ческа С.А., Сэндл Т.Cheşcă A., Cheşcă S.A., Sandle T.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://medecol.qmu.kz/jour/article/view/387

В представленной статье описан подход к исследованию дыхательной функции пациентов с острыми симптомами хронической обструктивной болезни легких. В специализированных медицинских отделениях было проведено обследование пациентов с использованием стандартного рентгенологического исследования грудной клетки с последующим использованием спирометрии в зависимости от тяжести симптомов пациента, с помощью теста бетамиметики. В результате как рентгенологическое исследование, так и спирометрия показали изменения в дыхательной функции пациентов, которые варьировались в зависимости от группы, в которую входили пациенты с хронической обструктивной болезнью легких.

The present study refers to the exploration of the respiratory function of patients who presented acute symptoms of chronic obstructive pulmonary disease. In the medical specialty units, examination was performed using a standard chest X-ray imaging investigation; followed by a spirometry test, according to the patient's severity of symptoms, using the betamimetics test. Both the X-ray result and the imaging investigation of spirometry showed changes. Changes varied according to the patients from different investigate disease groups in relation to chronic obstructive pulmonary disease.

хроническая обструктивная болезнь легкиххронический бронхитэмфиземастандартная рентгенография грудной клеткиспирометрияchronic obstructive pulmonary diseasechronic bronchitisemphysemastandard chest X-rayspirometryReferencesBaker W. L. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis /W. L. Baker, E. L. Baker, C. I. Coleman //Pharmacotherapy. – 2009. – V. 29(8). – P. 891-905.Baker W. L. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis /W. L. Baker, E. L. Baker, C. I. Coleman //Pharmacotherapy. – 2009. – V. 29(8). – P. 891-905.Chen A. M. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease /A. M. Chen, S. G. Bollmeier, P. M. Finnegan //Ann. Pharmacother. – 2008. – V. 42(12). – P. 1832-1842.Chen A. M. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease /A. M. Chen, S. G. Bollmeier, P. M. Finnegan //Ann. Pharmacother. – 2008. – V. 42(12). – P. 1832-1842.Ciappi G. Functional diagnosis of chronic obstructive pulmonary disease /G. Ciappi, G. Corbo, S. Valente //Ann. Ist. Super. Sanita. – 2003. – V. 39(4). – P. 529-547.Ciappi G. Functional diagnosis of chronic obstructive pulmonary disease /G. Ciappi, G. Corbo, S. Valente //Ann. Ist. Super. Sanita. – 2003. – V. 39(4). – P. 529-547.Cooper C. B. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease /C. B. Cooper, M. Dransfield //Am. J. Med. – 2008. – V. 121. – P. 33-45.Cooper C. B. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease /C. B. Cooper, M. Dransfield //Am. J. Med. – 2008. – V. 121. – P. 33-45.Hurst J. R. Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review /J. R. Hurst, J. A. Wedzicha //BMC Med. – 2009. V. 7. – P. 40.Hurst J. R. Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review /J. R. Hurst, J. A. Wedzicha //BMC Med. – 2009. V. 7. – P. 40.Izumi T. Definition of chronic obstructive disease //Nihon Rinsho. – 2003. – V. 61(12). – P. 2058-2070.Izumi T. Definition of chronic obstructive disease //Nihon Rinsho. – 2003. – V. 61(12). – P. 2058-2070.Puhan M. A. drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis /M. A. Puhan, L. M. Bachmann, J. Kleijnen //BMC Med. – 2009. – V. 7. – P. 2.Puhan M. A. drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis /M. A. Puhan, L. M. Bachmann, J. Kleijnen //BMC Med. – 2009. – V. 7. – P. 2.Reddy C. B. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease? /C. B. Reddy, R. E. Kanner //Drugs Aging. – 2007. – V. 24(8). – P. 615-628.Reddy C. B. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease? /C. B. Reddy, R. E. Kanner //Drugs Aging. – 2007. – V. 24(8). – P. 615-628.Romagnoli M. Chronic obstructive pulmonary disease: definition and classification of severity /M. Romagnoli, L. M. Fabbri //Ann. Ist. Super Sanita. – 2003. – V. 39(4). – P. 461-466.Romagnoli M. Chronic obstructive pulmonary disease: definition and classification of severity /M. Romagnoli, L. M. Fabbri //Ann. Ist. Super Sanita. – 2003. – V. 39(4). – P. 461-466.Sethi S. Bronchodilator combination therapy for the treatment of chronic obstructive pulmonary disease /S. Sethi, C. Cote //Curr. Clin. Pharmacol. – 2011. – V. 6(1). – P. 48-61.Sethi S. Bronchodilator combination therapy for the treatment of chronic obstructive pulmonary disease /S. Sethi, C. Cote //Curr. Clin. Pharmacol. – 2011. – V. 6(1). – P. 48-61.Yoshida M. General concepts and the history of chronic obstructive pulmonary disease //Nihon Kyobu Shikkan Gakkai Zasshi. – 1990. – V. 28(3). – P. 390-398.Yoshida M. General concepts and the history of chronic obstructive pulmonary disease //Nihon Kyobu Shikkan Gakkai Zasshi. – 1990. – V. 28(3). – P. 390-398.Yu T. Support of personalized medicine through risk-stratified treatment recommendations – an environmental scan of clinical practice guidelines /T. Yu, D. Vollenweider, R. Varadhan //BMC Med. – 2013. – V. 11. – P. 7.Yu T. Support of personalized medicine through risk-stratified treatment recommendations – an environmental scan of clinical practice guidelines /T. Yu, D. Vollenweider, R. Varadhan //BMC Med. – 2013. – V. 11. – P. 7.

The authors declare that there are no conflicts of interest present.